Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (1): 229-236.doi: 10.13481/j.1671-587x.20210132
• Review • Previous Articles Next Articles
-
Received:2020-07-24Online:2021-01-28Published:2021-01-27
CLC Number:
- R739.86
Cite this article
share this article
| 1 | KOVACS G.Modern head and neck brachytherapy： from radium towards intensity modulated interventional brachytherapy［J］. J Contemp Brachytherapy，2015，6（4）：404-416. |
| 2 | MAZERON J J， ARDIET J M，HAIE-MÉDERCHRISTINE C， et al.GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas［J］. Radiother Oncol，2009， 91（2）：150-156. |
| 3 | BANSAL A， GHOSHAL S， OINAM A S， et al. High-dose-rate interstitial brachytherapy in early stage oral tongue cancer-15 year experience from a tertiary care institute［J］. J Contemp Brachytherapy， 2016， 8 （1）：56-65. |
| 4 | CHEN S W， ZHANG Q ， GUO Z M， et al. Trends in clinical features and survival of oral cavity cancer： fifty years of experience with 3，362 consecutive cases from a single institution［J］. Cancer Manag Res， 2018， 10：4523-4535. |
| 5 | KOVACS G，MARTINEZ-MONGE R， BUDRUKKAR A， et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas： 1st update-Improvement by cross sectional imaging based treatment planning and stepping source technology［J］. Radiother Oncol， 2017， 122（2）： 248-254. |
| 6 | TAKÁCSI-NAGY Z， MARTÍNEZ-MONGUE R， MAZERON J J， et al.American Brachytherapy Society Task Group Report： Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies［J］. Brachytherapy， 2017， 16（1）： 44-58. |
| 7 | HAIE-MÉDER C， MAROUN P， FUMAGALLI I， et al. Pourquoi la curiethérapie reste-t-elle indispensable en 2017？ ［J］.Cancer Radiother， 2018，22（4）：307-311. |
| 8 | HELLEBUST T P. Place of modern imaging in brachytherapy planning［J］. Cancer Radiother， 2018，22（4）：326-333. |
| 9 | AKIYAMA H，PESZNYAK C，BELA D， et al. Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer： A comparative analysis of dosimetry for target volume and organs at risk［J］. Radiol Oncol， 2018， 52（4） ：461-467. |
| 10 | OTTER S J， STEWART A J， DEVLIN P M. Modern brachytherapy［J］. Hematol Oncol Clin North Am， 2019， 33（6）：1011-1025. |
| 11 | TANDERUP K， MENARD C， POLGAR C， et al. Advancements in brachytherapy［J］. Adv Drug Deliv Rev， 2017， 109：15-25. |
| 12 | RUDOLTZ M S， PERKINS R S， LUTHMANN R W， et al. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx［J］. Laryngoscope， 1999， 109（12）：1967-1973. |
| 13 | INOUE T， INOUE T， YOSHIDA K Y， et al. Phase Ⅲ trial of high-vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer［J］. Int J Radiat Oncol Biol Phys，2001，51（1）：171-175. |
| 14 | PFISTER D G， SPENCER S， ADELSTEIN D， et al. Head and neck cancers， version 2. 2020， NCCN clinical practice guidelines in oncology［J］. J Natl Compr Canc Netw， 2020，18（7）：873-898. |
| 15 | 李晔雄. 肿瘤放射治疗学［M］.5版.北京：中国协和医科大学出版社， 2018：447-469. |
| 16 | OMURA K. Current status of oral cancer treatment strategies： surgical treatments for oral squamous cell carcinoma［J］. Int J Clin Oncol， 2014，19（3）：423-430. |
| 17 | MANNELLI G， ARCURI F， AGOSTINI T， et al. Classification of tongue cancer resection and treatment algorithm［J］. J Surg Oncol， 2018，117（5）：1092-1099. |
| 18 | STRNAD V. Treatment of oral cavity and oropharyngeal cancer.Indications， technical aspects， and results of interstitial brachytherapy［J］. Strahlenther Onkol，2004，180（11）：710-717. |
| 19 | CHAKRABARTI B， GHORAI S， BASU B S，et al.Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy：an institutional experience of 42 cases in India［J］. Brachytherapy，2010，9（3）：254-259. |
| 20 | FUKANO H， MATSUURA H， HASEGAWA Y， et al.Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma［J］. Head Neck，1997，19（3）：205-210. |
| 21 | BALASUBRAMANIAN D， EBRAHIMI A， GUPTA R，et al.Tumour thickness as a predictor of nodal metastases in oral cancer： Comparison between tongue and floor of mouth subsites［J］. Oral Oncol，2014， 50（12）：1165-1168 |
| 22 | POTHARAJU M，HEMANTHRAJ E，MUTHUKUMARAN M， et al.Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer［J］. J Contemp Brachytherapy， 2018， 10（1）：64-72. |
| 23 | GANLY I， PATEL S， SHAH J. Early stage squamous cell cancer of the oral tongue：clinicopathologic features affecting outcome［J］. Cancer，2012，118（1）： 101-111. |
| 24 | LIU J C， SOPKA D S， MEHRA R， et al. Early oral tongue cancer initially managed with surgery alone： Treatment of recurrence［J］. World J Otorhinolaryngol Head Neck Surg，2016， 2（4）： 193-197. |
| 25 | PARIKH H K， RAO R S， SUKHTHANKAR P，et al. Surgery in early cancer of the oral tongue （T1-2）. Wide excision versus hemiglossectomy［J］. Indian J Otolaryngol Head Neck Surg，1998， 50（4）：349-353. |
| 26 | OKAMOTO， TAKASHI， AKIYAMA， et al. High-dose-rate interstitial brachytherapy for tongue cancer ： a radiological and biological study from the perspective of late complications［J］. J Osaka Dent Univ， 2012， 46（1）：57-62. |
| 27 | SHIM S J， CHA J， KOOM W S， et al. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy［J］. Radiat Oncol，2010， 5（1）：43-49. |
| 28 | STRNAD V， POTTER R， KOVACS G， et al. Practical handbook of brachytherapy，Chapter 18：ENT tumours［M］. Bremen-London Boston：UNI-MED Verlag，2014： 166-183. |
| 29 | PELLIZZON A C， SALVAJOLI J V， KOWALSKI L P， et al. Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy［J］. Radiat Oncol，2006，1（1）：27-43. |
| 30 | LAPEYRE M， BIAU J， RACADOT S， et al.Radiothérapie des cancers de la cavité buccale［J］. Cancer Radiother，2016， 20：S116-S125. |
| 31 | AKIYAMA H，YOSHIDA K，SHIMZUTANI K， et al. Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer［J］. J Radiat Res，2012，53（5）：722-726. |
| 32 | NISHIOKA T， HOMMA A， FURUTA Y， et al. A novel approach to advanced carcinoma of the tongue： cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy［J］. Jpn J Clin Oncol， 2006，36（12）：822-826. |
| 33 | PEIFFERT D， COCHE-DEQUÉANT B， LAPEYRE M，et al. Curiethérapie des cancers de la tête et du cou： synthèse des recommandations européennes et principales indications［J］.Cancer Radiother， 2018，22（4）：359-366. |
| 34 | MARTÍNEZ-MONGE R， PAGOLA DIVASSÓN M， CAMBEIRO M， et al. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high–dose rate brachytherapy （PHDRB）［J］. Int J Radiat Oncol Biol Phys， 2011， 81（4）：E245-E254. |
| 35 | 谷铣之，殷蔚伯. 肿瘤放射治疗学［M］.4版. 北京：中国协和医科大学出版社， 2015：335-336. |
| 36 | MAYADEV J， BENEDICT S H， KAMRAVA M. Handbook of image-guided brachytherapy ［M］. New York ：Springer International Publishing， 2017：219-273. |
| 37 | YOSHIDA K ， KOTSUMA T ， AKIYAMA H ， et al. A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer［J］. J Contemp Brachytherapy， 2019， 11（6）：573-578. |
| 38 | 谢丽娜，高诚宜，李 毅，等.精准放疗质控保证—位置/剂量监测技术研究进展[J].西安交通大学学报(医学版)，2020,41(1)：7-12. |
| 39 | 岳 堃,姚 原,贾晓斌,等.基于smart LMC算法的动态调强技术在舌癌术后放疗中的剂量学研究[J].中国医学物理学杂志,2019,36(11)：1255-1260. |
| 40 | AKIYAMA H， YOSHIDA K， YAMAZAKI H， et al. High-dose-rate interstitial brachytherapy for mobile tongue cancer： preliminary results of a dose reduction trial［J］. J Contemp Brachytherapy， 2014， 6（1）：10-14. |
| 41 | YAMAZAKI H. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer ： influence of age on outcome［J］. Anticancer Res， 2007，27（1b）：491-497. |
| 42 | KAKIMOTO N， INOUE T， INOUE T， et al. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer［J］. Radiother Oncol， 2003， 68（2）：123-128. |
| 43 | SHNTOS M A，GUINOT J L，TORTAJADA M I， et al. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma［J］.Brachytherapy，2017，68（6）：123-128. |
| 44 | CISEK P， KIESZKO D， BRZOZOWSKA A， et al. Image-guided high-dose-rate brachytherapy of head and neck-a case series study［J］. J Contemp Brachytherapy， 2016， 8（6）：544-553. |
| 45 | BHALAVAT R， CHANDRA M， PAREEK V， et al. High-dose-rate interstitial brachytherapy in head and neck cancer： do we need a look back into a forgotten art-a single institute experience［J］.J Contemp Brachytherapy， 2017， 9（2）：124-131. |
| 46 | GUINOT J L， SANTOS M， TORTAJADA M I， et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma［J］. Brachytherapy， 2010， 9（3）：227-234. |
| 47 | KAZEMIAN A，BABAEI M，LASHKARI M， et al. Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers： 5 years of experience in Iran［J］. J Contemp Brachytherapy， 2017， 9（4）：323-329. |
| 48 | LEE S U， CHO K H， MOON S H， et al. Clinical outcome of high-dose-rate interstitial brachytherapy in patients with oral cavity cancer［J］. Radiat Oncol J，2014， 32（4）：238-246. |
| 49 | PLATTEAUX N， DIRIX P， VANSTRAELEN B， et al. Outcome after re-irradiation of head and neck cancer patients［J］. Strahlenther Onkol，2011，187（1）：23-31. |
| 50 | HIDEYA Y， KEN Y， YASUO Y， et al. High dose rate brachytherapy for oral cancer［J］. J Radiat Res， 2013，54（1）：1-17. |
| [1] | Lu LIU,Tianfu ZHANG,Xiaofeng WANG,Chenfei KONG. Regulatory effects of syndecan-1 on migration, invasion and cell cycle of tongue squamous cell carcinoma CAL27 cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 59-65. |
| [2] | ZHANG Chu, HAO Miao, WANG Huiyu, WANG Xiaofeng, ZHANG Tianfu. Effect of Oxaliplatin on proliferation and apoptosis of human tongue squamous cell carcinoma CAL27 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 233-239. |
| [3] | WANG Huiyu, ZHANG Tianfu, HAO Miao, ZHANG Chu, WANG Xiaofeng. Inhibitory effect of polysaccharides from panax ginseng fruit on proliferation of human lingual squamous cell carcinoma CAL27 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 248-253. |
| [4] | LI Haobo, DU Yong, CHEN Yong, LI Wenjing. Influence of Notch 1 in expression of EGFR in tongue squamous cell carcinoma Tca8113 cells [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 715-719. |
| [5] | SUN Bin, WANG Yue, YIN Guoxiang, DU Baoxia, YU Ziying, ZHANG Wei. Clinical application of lateral upper arm flap in repairing postoperative soft tissue defects of tongue cancer patients [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 408-411. |
| [6] | DUAN Xiumei, LI Shuoxi, MING Zhihui, ZHANG Congxiao, LIU Wenshu. Expressions of Cks1,Skp2,and p27kip1 proteins in tongue squamous cell carcinoma tissue and their clinical significances [J]. Journal of Jilin University Medicine Edition, 2015, 41(02): 347-351. |
| [7] | YANG Cai-ling,ZhANG Jing-hang,ZHANG Ying-hua,REN Ming-xin,LIU Jin-zhong,CUI Wei-gang. Induction effect of icotinib on apoptosis of salivary adenoid cystic carcinoma ACC-M cells through p38-MAPK pathway [J]. Journal of Jilin University Medicine Edition, 2014, 40(04): 820-823. |
| [8] | LI Xiang,ZHANG Bin,MA Jing，GAO Qi，SHI Yi. Influence of Akt inhibitor MK2206 in proliferation and apoptosis of tongue squamous cell carcinoma TCA-8113 cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(03): 616-625. |
| [9] | DONG Xiao-ting,ZHANG Bin,LIU Shuo-shuo,GUO Ting-ting,PANLiang-peng,JIA Ni. Construction of PTEN gene eukaryotic expressing vector and its expression in tongue squamous cell carcinoma SCC-4 cell line [J]. Journal of Jilin University Medicine Edition, 2013, 39(2): 282-285. |
| [10] | GUO Ting-ting,ZHANG Bin，LIU Jia-bai,LIU Shuo-shuo,DONG Xiao-ting. Influence of PTEN in invasion and expression of epithelial-mesenchymal transition related protein in tongue squamous cell car cinoma [J]. Journal of Jilin University Medicine Edition, 2013, 39(1): 70-73. |
| [11] | HAN Wen-zhi，CHEN Ying-xin，LIU Wen-shu. Effects of chemotherapeutic drugs on proliferationof tongue carcinoma cells [J]. J4, 2006, 32(4): 672-674. |
| [12] | HUANG Han,LI Fang-qiu,ZHANG Bin,MA Jing. Expressions of Livin and Cyt-C in tongue squamous cell carcinoma tissue and their clinical significances [J]. Journal of Jilin University Medicine Edition, 2013, 39(6): 1233-1236. |
| [13] | LIU Zhihui, YANG Wei. Suppressive effect of hesperetin on growth of tongue cancer cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2015, 41(03): 558-562. |
| [14] | SHI Yi, JIN Xiaohong, WU Weizhong, HUO An, ZHOU Wei, HUANG Han. Effects of isobavachalcone on proliferation and apoptosis of tongue squamous cell carcinoma Tca-8113 cells and their mechanisms [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 725-730. |
| [15] | HAN Chunyao, ZHANG Bin, MA Xue, LIU Mingyuan, XUE Zhongyuan, HAO Lijing, GE Shuqing. Establishment of tongue squamous cell carcinoma TSCCA cell model with silencing α-catulin gene [J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 481-485. |
|
